Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
Holding FULC?
Track your performance easily
See the Price Targets and Ratings of:
FULC Analyst Ratings
Hold
1 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FULC Stock 12 Month Forecast
Average Price Target
$5.80
▲(33.33% Upside)
| Highest Price Target$14.00 | Average Price Target$5.80 | Lowest Price Target$3.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
11/14/24
H.C. Wainwright
Reiterated
11/14/24
Oppenheimer
Reiterated
11/14/24
RBC Capital
Reiterated
11/13/24
Stifel Nicolaus
Reiterated
09/26/24
Cantor Fitzgerald
―
Hold
―
Downgraded
09/12/24
Fulcrum Therapeutics downgraded to Neutral from Overweight at Cantor FitzgeraldFulcrum Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
Bank of America Securities
$10→$2
Sell
-54.02%
Downside
Downgraded
09/12/24
Fulcrum Therapeutics downgraded to Underperform from Neutral at BofAFulcrum Therapeutics downgraded to Underperform from Neutral at BofA
Goldman Sachs
―
Buy
―
Reiterated
07/31/24
Fulcrum Therapeutics: A Strong Buy on Accelerated Clinical Progress and Strategic Focus
Piper Sandler
$16
Buy
267.82%
Upside
Reiterated
07/19/24
Fulcrum Therapeutics (FULC) Receives a Buy from Piper Sandler
Best Analysts Covering Fulcrum Therapeutics
Which Analyst Should I Follow If I Want to Buy FULC and Sell After:
1 Month
xxx
Success Rate
6/9 ratings generated profit
Average Return
+6.99%
downgraded a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +6.99% per trade.
3 Months
xxx
Success Rate
4/9 ratings generated profit
Average Return
-5.21%
downgraded a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -5.21% per trade.
1 Year
Success Rate
6/12 ratings generated profit
Average Return
+21.26%
reiterated a buy rating last month
Copying Matthew Biegler's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +21.26% per trade.
2 Years
xxx
Success Rate
4/9 ratings generated profit
Average Return
+0.29%
downgraded a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 44.44% of your transactions generating a profit, with an average return of +0.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FULC Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
9
11
5
3
2
Buy
3
1
1
0
0
Hold
0
0
7
8
11
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
13
13
14
12
14
Each month's total comprises the sum of three months' worth of ratings.
FULC Financial Forecast
FULC Stock Forecast FAQ
What is FULC’s average 12-month price target, according to analysts?
Based on analyst ratings, Fulcrum Therapeutics’s 12-month average price target is $5.80.
What is FULC’s upside potential, based on the analysts’ average price target?
Fulcrum Therapeutics has 33.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FULC a Buy, Sell or Hold?
Fulcrum Therapeutics has a consensus rating of Hold which is based on 1 buy ratings, 4 hold ratings and 0 sell ratings.
What is Fulcrum Therapeutics’s price target?
The average price target for Fulcrum Therapeutics is $5.80. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $14.00 ,the lowest forecast is $3.00. The average price target represents 33.33% Increase from the current price of $4.35.
The highest analyst price target is $14.00 ,the lowest forecast is $3.00. The average price target represents 33.33% Increase from the current price of $4.35.
What do analysts say about Fulcrum Therapeutics?
Fulcrum Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of FULC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.